A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
NCT00509873
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
578
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Conjunctivitis
Interventions
DRUG:
Gatifloxacin 0.5% eye drops
DRUG:
placebo eye drops
Sponsor
Allergan